- 10 June
-
The Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, a collective member of the Ural Biomedical Cluster, has participated in the CHEMTECH URAL, first specialised forum and exhibition, held from May 26 to 28 in the Ekaterinburg-EXPO International Exhibition Centre. The organization acted as an industry partner for the event, bringing together key players from the pharmaceutical and chemical sectors of the region at its joint booth.
- 10 June
-
Pharmaceutical Chemistry: Towards Full-Cycle Production round table discussion was held as part of the business program at ChemTech Ural 2026. Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, was the keynote speaker at the event.
- 10 June
-
Medsintez Plant, one of Russia's leading manufacturers of insulins and drugs for the therapy of socially significant diseases, traditionally participated in the 11th (32nd) National Congress of Endocrinologists with International Participation. The event, themed Personalized Medicine in Endocrinology: From Fundamental Science to Clinical Practice, took place from 26 to 29 May in Moscow.
- 10 June
-
In 2025, the Governor of the Sverdlovsk Region, Denis Vladimirovich Pasler, signed a decree awarding the Regional Head's Certificate of Honour to Alexey Borisovich Podkorytov, CEO of Medsintez Plant LLC.
- Home
- Cluster members
- Medica Group LLC
Medica Group LLC
Medica Group LLC is engaged in the localization of a joint Russian-Chinese project for the production of automatic microbiology analyzers on the territory of priority development in Novouralsk. The corresponding document was signed in the management company of the territory of advanced social and economic development (TASED) Atom- TOR. The project of localization of production in Russia was our response to the imposition of sanctions and threats of vital product lack. This project for the production of analyzers and culture vials gives us independence from foreign supplies.
Areas of company activities:
- Laboratory consumables;
- Modern solutions for microbiological laboratories;
- Medical equipment;
Clinical microbiology is an important link in the study of pathogenic features, pathogen diagnosis, rational use of antimicrobials and monitoring of nosocomial infection.
Sepsis is a fatal disease. About 30% of patients are misdiagnosed. This is due to the fact that current detection methods have low specificity and are slow. It takes days to get results, leading doctors to prescribe ineffective antibiotics, which in turn leads to the spread of antibiotic-resistant strains and increased deaths caused by blood infections. Every hour of delay in the use of effective antibiotics reduces survival by 7.6%. The introduction of innovative technologies in microbiological laboratories allows raising diagnostics to a new level, reducing the time for issuing results to 18-24 hours.
Automatic analyzers using advanced technology:
- YUNONA®LABSTAR model for testing the sterility of blood cultures and other biological fluids;
- Vials for blood cultures;
- YUNONA® HK model for identification of microorganisms and determination of sensitivity to antibiotics;
- Reagent kits for identification and sensitivity to antibiotics;
Automation of microbiological laboratories is an increase in the efficiency that directs the diagnosis, treatment and prevention of infectious diseases to obtain a quick and accurate diagnosis.
Medica Group of companies
Phone: +7 (343) 270-75-17
E-mail: medica.group@mail.ru
Website: medicagroup.ru
